• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,371
2,300
1,859
1,847
1,725

COUNTRY

866
647
270
253
211

CATEGORIES

  • 858
  • 186
  • 679
  • 1,126
  • 391
  • 270
  • 252
  • 65
  • 378
  • 687
  • 1,330
  • 1,355
  • 625
  • 884
  • 1,695
  • 2,675
  • 507
  • 732
  • 0
  • 93

PRICE

6,792
11,418
17,937
25,138

PUBLISHED

1,978
2,674
7,334
25,138

PRODUCT TYPE

21,015
2,901
871
164
75
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Axxess Pharma, Inc.,(AXXE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Axxess Pharma, Inc.,(AXXE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Axxess Pharma, Inc.,(AXXE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Axxess Pharma, Inc. (AXXE), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
CML Healthcare Inc,(CLC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages CML Healthcare Inc,(CLC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

CML Healthcare Inc,(CLC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for CML Healthcare Inc (CLC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Cornerstone Therapeutics Inc,(CRTX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Cornerstone Therapeutics Inc,(CRTX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Cornerstone Therapeutics Inc,(CRTX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Cornerstone Therapeutics Inc (CRTX), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Isotechnika Pharma Inc,(ISA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Isotechnika Pharma Inc,(ISA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Isotechnika Pharma Inc,(ISA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Isotechnika Pharma Inc (ISA), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Kiwa Bio-Tech Products Group Corporation,(KWBT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Kiwa Bio-Tech Products Group Corporation,(KWBT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Kiwa Bio-Tech Products Group Corporation,(KWBT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kiwa Bio-Tech Products Group Corporation (KWBT), plus vital industry benchmarks and extensive operating ratios,...

October 2013
FROM
Mannatech Inc,(MTEX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Mannatech Inc,(MTEX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Mannatech Inc,(MTEX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Mannatech Inc (MTEX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Pulmo BioTech, Inc.,(PLMO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Pulmo BioTech, Inc.,(PLMO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Pulmo BioTech, Inc.,(PLMO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Pulmo BioTech, Inc. (PLMO), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Questcor Pharmaceuticals Inc,(QCOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Questcor Pharmaceuticals Inc,(QCOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Questcor Pharmaceuticals Inc,(QCOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Questcor Pharmaceuticals Inc (QCOR), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Immunovaccine Inc.,(IMV) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Immunovaccine Inc.,(IMV) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Immunovaccine Inc.,(IMV) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Immunovaccine Inc. (IMV), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Tesaro Inc,(TSRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Tesaro Inc,(TSRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Tesaro Inc,(TSRO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Tesaro Inc (TSRO), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
TherapeuticsMD Inc,(TXMD) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages TherapeuticsMD Inc,(TXMD) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

TherapeuticsMD Inc,(TXMD) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for TherapeuticsMD Inc (TXMD), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Trius Therapeutics Inc,(TSRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Trius Therapeutics Inc,(TSRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Trius Therapeutics Inc,(TSRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Trius Therapeutics Inc (TSRX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Vanda Pharmaceuticals, Inc.,(VNDA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Vanda Pharmaceuticals, Inc.,(VNDA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Vanda Pharmaceuticals, Inc.,(VNDA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Vanda Pharmaceuticals, Inc. (VNDA), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
VG Life Sciences Inc,(VGLS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages VG Life Sciences Inc,(VGLS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

VG Life Sciences Inc,(VGLS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for VG Life Sciences Inc (VGLS), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Radient Pharmaceuticals Corp,(RXPC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Radient Pharmaceuticals Corp,(RXPC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Radient Pharmaceuticals Corp,(RXPC) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Radient Pharmaceuticals Corp (RXPC), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Repros Therapeutics Inc,(RPRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Repros Therapeutics Inc,(RPRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Repros Therapeutics Inc,(RPRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Repros Therapeutics Inc (RPRX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
S&W Seed Co,(SANW) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages S&W Seed Co,(SANW) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

S&W Seed Co,(SANW) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for S&W Seed Co (SANW), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Seattle Genetics,(SGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Seattle Genetics,(SGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Seattle Genetics,(SGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Seattle Genetics (SGEN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
SignPath Pharma, Inc.,(SGTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages SignPath Pharma, Inc.,(SGTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

SignPath Pharma, Inc.,(SGTH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for SignPath Pharma, Inc. (SGTH), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Spectral Diagnostics Inc,(SDI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Spectral Diagnostics Inc,(SDI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Spectral Diagnostics Inc,(SDI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Spectral Diagnostics Inc (SDI), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos